Related Experiment Videos
Plasmid transfer and behaviour in Acinetobacter calcoaceticus EBF65/65.
Journal of General Microbiology
|October 1, 1985
Summary
Plasmids from various incompatibility groups can transfer from Escherichia coli to Acinetobacter calcoaceticus. Some transfers were influenced by specific plasmids, and many trimethoprim resistance plasmids showed successful transfer.
Area of Science:
- Microbiology
- Genetics
- Molecular Biology
Background:
- Bacterial conjugation is a key mechanism for horizontal gene transfer.
- Understanding plasmid transfer between different bacterial species is crucial for tracking antibiotic resistance.
- Acinetobacter calcoaceticus is an important opportunistic pathogen, and its genetic manipulation is of interest.
Purpose of the Study:
- To investigate the transferability of plasmids from Escherichia coli K12 to Acinetobacter calcoaceticus EBF65/65.
- To assess the influence of recipient strain factors and plasmid incompatibility groups on transfer efficiency.
- To evaluate the stability and re-transfer capability of plasmids in Acinetobacter calcoaceticus.
Main Methods:
- Conjugation experiments were performed to transfer plasmids from E. coli K12 to A. calcoaceticus EBF65/65.
- Plasmids from multiple incompatibility groups (B, C, FIV, H2/S, Iα, Iδ, P, W, X) were tested.
- The effect of the pAV2 plasmid in the recipient strain was examined, along with the transfer of trimethoprim resistance plasmids.
Main Results:
- Plasmids from all tested incompatibility groups were capable of transfer to A. calcoaceticus EBF65/65.
- The presence of pAV2 in the recipient influenced transfer, but not uniformly across all plasmids.
- 31 out of 40 trimethoprim resistance plasmids successfully transferred, with 17 requiring a mobilizing plasmid for re-transfer.
Conclusions:
- Plasmids exhibit broad transferability from E. coli to A. calcoaceticus, irrespective of incompatibility group.
- Plasmid stability in A. calcoaceticus varies, but re-transfer to E. coli is possible.
- This study highlights the potential for interspecies plasmid transfer, including clinically relevant resistance genes.